Categories: News

Nebraska Health Information Initiative (NEHII) recognized as CMS Submitter for Quality Payment Program for 2021

OMAHA, Neb., Dec. 21, 2020 /PRNewswire/ — Nebraska Health Information Initiative (NEHII) is pleased to announce that the Centers for Medicare and Medicaid Services (CMS) recognized NEHII as a Qualified Clinical Data Registry (QCDR) for 2021.

A QCDR is a CMS-approved entity that collects clinical data for the purpose of quality improvement regarding the care furnished to patients. QCDRs are one of several available reporting mechanisms for eligible clinicians and groups for the Merit-Based Incentive Payment System (MIPS), Primary Care First (PCF) and other CMS Quality Payment Program (QPP) payment models.

“At NEHII, we strive to advance interoperability and provide value by ensuring that providers have access to and understand data so it can be used to expedite decision-making and uncover opportunities for a healthier life and community,” said Jaime Bland, NEHII’s President and Chief Executive Officer. “Being recognized as a QCDR allows us to do just that – and more, reducing the burden of participating and transitioning to value-based care.”

Being a QCDR also allows NEHII to streamline the data collection process for MIPS, PCF, and other QPP models, as well as support providers in earning credit in multiple MIPS performance categories. NEHII QCDR participants receive real-time reports and scorecards on quality metrics, enabling proactive quality and process improvement.

NEHII is empowered to reduce multiple burdens of clinical quality reporting, provide dashboard monitoring of quality data and deliver actionable patient care reports to prioritize resources. As a QCDR, NEHII has a secondary certification from the CMS Qualified Entity Certification Program (QECP) that enables NEHII to receive Medicare data, including Parts A, B, and D claims data on behalf of affiliated providers. As a Quasi Qualified Entity (QE), NEHII can provide combined clinical and claims analytics which contributes to more a comprehensive patient longitudinal health record, as well as population level insights.

This is the third year for NEHII to be recognized as a QCDR; the first being in 2018. 

About NEHII

NEHII’s mission is to bring trust and value to health information technology by creating solutions for moving health data forward. NEHII, Inc. is a 501(c)3 non-profit organization with a public/private governance model that includes health care providers, payers, and the State of Nebraska. NEHII is the designated statewide Health Information Exchange designed to share clinical and administrative data among providers in Nebraska and neighboring states. NEHII’s purpose is to achieve health care transformation through community betterment collaboration while protecting the security and privacy of medical information. Follow us on FacebookLinkedIn, and Twitter.

View original content to download multimedia:http://www.prnewswire.com/news-releases/nebraska-health-information-initiative-nehii-recognized-as-cms-submitter-for-quality-payment-program-for-2021-301197056.html

SOURCE NEHII

Staff

Recent Posts

Cardiol Therapeutics Achieves Key 50% Patient Enrollment Milestone in Pivotal Phase III MAVERIC Trial in Recurrent Pericarditis

Clinical trial infrastructure fully operational in the U.S. with more than 15 leading cardiovascular centers…

15 minutes ago

CannaPharmaRX Provides Corporate Update and Outlines Growth Strategy for 2026

CALGARY, AB / ACCESS Newswire / January 12, 2026 / CannaPharmaRX, Inc. (OTC PINK:CPMD), an…

11 hours ago

TempraMed Closes C$2.5 Million Fully Subscribed Private Placement

Vancouver, British Columbia--(Newsfile Corp. - January 12, 2026) - TempraMed Technologies Ltd. (CSE: VIVI) (FSE:…

14 hours ago

TruuCONNECT NJ Statewide Digital Hub Empowers Users to Find Verified, Local Community Resources and Support – Anonymously and in Real Time

MOUNT LAUREL, N.J., Jan. 12, 2026 /PRNewswire/ -- Born out of a partnership between the…

14 hours ago

Nuvo Unveils Large-Scale AI-Ready Pregnancy Dataset Built on Real-World Maternal and Fetal Physiology

Unique longitudinal dataset combining native fetal and maternal ECG with phonocardiography supports deeper insights into…

14 hours ago

Alamar Biosciences Announces Launch of NULISAqpcr™ AD 5-plex Assay, Advancing Blood Based Biomarker Detection in Alzheimer’s Disease Research

FREMONT, Calif., Jan. 12, 2026 /PRNewswire/ -- Alamar Biosciences, Inc. ("Alamar"), a leader in precision…

14 hours ago